Intranasal LAIV Mucosal Immunity Examination
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 25 people, planned
- Starts
- Feb 2027
- Expected to end
- Jul 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Live Attenuated Influenza Vaccine
- Record updated
- 3 September 2026
Who can take part
- Age
- 2 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Patient undergoing tonsillectomy and adenoidectomy as part of the standard of care for sleep apnea
Who cannot take part
- Already received this year's flu vaccine
- Chronic Tonsillitis
- Immune Deficiency
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Impact of vaccination
Where in United States
- University of Maryland Medical CenterBaltimore, United StatesContact: Adam Kaufman, MD PhDNot yet recruiting
About the trial
What the trial wants to find out
The research of the investigators is focused on the understanding how the immune system functions and responds to intranasal vaccines. Intranasal vaccines do not lead to the same changes in the blood that intramuscular vaccines do. Therefore, the investigators want to look at the function of immune (lymphoid) organs that are near the nose. The closest immune organs are the adenoids and tonsils. Mice do not have tonsils allowing for the investigators to answer these questions. Human lymphoid tissue will allow the investigators to better understand the molecular behavior of these cells in humans.
Read full original descriptionShow less
The purpose of this protocol is to administer the FDA approved live attenuated influenza vaccine or no vaccine to patients undergoing adenoidectomy and/or tonsillectomy for obstructive sleep apnea prior to surgery and then collect the tissue (adenoid and/or tonsil tissue) that would normally be discarded from surgery. This will allow for improved understanding of what happens after vaccination.
The 2 groups in the trial
- Interventional LAIVTreatment being tested
Intranasal Flu Vaccine
Treatment: Live Attenuated Influenza Vaccine
- No InterventionNo study treatment, for comparison
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Impact of Live Attenuated Intranasal Influenza Vaccine Exposure on Mucosal Immunity
- Criteria questions
- Built from NCT07093281, who can take part
- Record updated
- 3 September 2026